A California federal jury found that a Monsanto Roundup weed killer caused a 70-year-old man's cancer, the company's second biggest blow in a year.
San Francisco Federal Court's panel of six judges concluded on Tuesday that glyphosate, the major constituent of Roundup, is a "major factor" in Sonoma's non-Hodgkin's lymphoma.
The jury's verdict is the second in a long list of future lawsuits. According to the company's annual report filed with the Securities and Exchange Commission (SEC), about 11,200 plaintiffs alleging that they were exposed to glyphosate filed suit on January 28.
According to Hardeman's lawyers, the older man developed non-Hodgkin's lymphoma after using Roundup to spray his properties for nearly three decades.
On Wednesday, the trial against Hardeman began in the second phase, in which the jury decides whether the company is liable and Hardeman has possibly awarded damages. The next phase will focus on how groundup was marketed and whether the company has hidden the alleged risks of the product.
A Hardeman lawyer was not immediately available for comment.
In August 201
Monsanto was acquired last year by the pharmaceutical company Bayer for $ 63 billion.
Bayer defended its product in a statement.
"We are disappointed with the jury's original decision, but we remain firmly convinced that science confirms that glyphosate-based herbicides do not cause cancer." We are confident that the evidence in Phase Two will show that Monsanto's behavior it was appropriate that the company should not be liable for Mr. Hardeman's cancer, "the company said.
"Already in the 1980s, Monsanto was known for the carcinogenic properties of glyphosate." The claim of Hardeman is asserted. In 1985, the Department of Toxicology of the Environmental Protection Agency ("EPA") published a memo glyphosate as "possible human carcinogens" with limited evidence of carcinogenicity. "
The lawsuit lists several studies linking glyphosate to cancerous behavior. The American Cancer Society calls the substance a "likely carcinogen" and states it is "probably carcinogenic to humans" by the International Agency for Research on Cancer, a part of the World Health Organization.
Bayer claims to have submitted more than 800 studies to EPA, European and other regulators, "confirming that these products are safe when used as intended," including a 2018 independent long-term study supported by the National Cancer Institute, in which " no link was found between glyphosate "herbicides and cancer," according to the company's statement.
Bayer stock hit the news hard on Wednesday, dropping nearly 10 percent, or $ 1.83, to close at $ 17.84 per share.